Differentiating leukemia subtypes based on metabolic signatures using hyperpolarized ¹³C NMR

Area of Science:

• Biochemistry
• Oncology
• Medical Imaging

Background:

• Leukemia comprises diverse subtypes with similar origins, complicating diagnosis and treatment.
• The Warburg effect, a deranged metabolic phenotype, is characteristic of cancer cells, including leukemia.
• Distinguishing between leukemia subtypes is critical for effective therapeutic strategies.

Purpose of the Study:

• To characterize metabolic signatures of six leukemia cell lines using hyperpolarized 13C NMR spectroscopy.
• To evaluate the potential of this technique in differentiating leukemia subtypes with similar origins.
• To explore the application of metabolic profiling for enhanced leukemia disease management.

Main Methods:

• Utilized hyperpolarized 13C Nuclear Magnetic Resonance (NMR) spectroscopy.
• Employed [1-13C]pyruvate and [1-13C]alanine as metabolic bioprobes.
• Analyzed cultured leukemia cell lines (ML-1, CCRF-CEM, THP-1, MOLT-4, HL-60, K562) with and without 2-deoxy-D-glucose treatment.

Main Results:

• Successfully differentiated metabolic signatures between various leukemia subtypes, including AML and T-ALL lineages.
• Demonstrated the ability to distinguish between closely related subtypes like M4/M5 AML and M1/M2 AML.
• Showcased distinct metabolic profiles for T-ALL cell lines at different maturation stages.

Conclusions:

• Hyperpolarized 13C NMR spectroscopy is a powerful tool for differentiating leukemia subtypes.
• This metabolic analysis method holds significant potential for improving leukemia diagnosis.
• Integration with bioreactor systems could enable personalized leukemia management through repeated metabolic assessments from single biopsies.